nci-match trial reveals actionable mutations and matches cancer patients to targeted therapies
Published 3 years ago • 64 plays • Length 20:08Download video MP4
Download video MP3
Similar videos
-
20:20
nci-match
-
18:16
cancer healthcast: nci precision medicine study hones in on cancer remission
-
10:08
nci-match: pioneering a new era in cancer treatment
-
1:08
preliminary findings from the nci-match trial for mismatch repair-deficient
-
3:14
nci-match/eay131 precision medicine cancer trial – spring 2021 update
-
3:43
targeted therapy benefit for actionable mutations
-
1:09:17
breast cancer clinical trials: an inside look at immunotherapy
-
59:50
march 2023 case conference webinar
-
38:24
new data and changing decisions in lymph node surgery for melanoma
-
3:50
[pancreas] role of olaparib in stage 4 pancreatic cancer patients with brca mutations
-
7:01
cardiovascular fitness improves breast cancer recovery
-
1:50
meet gynecologic oncologist nicole fleming, m.d.
-
1:50
meet gynecologic oncologist nicole fleming, m.d.
-
3:10
how mutation screening impacts transplant decisions in mds
-
16:22
advanced dna sequencing test used to match rare cancers
-
1:45
nci-connect clinic: why participate
-
1:36
nccn guidelines on molecular assays for patients with breast cancer
-
2:43
should mpn patients be retested for mutations over time?
-
6:57
case 1: patient choice in initiating ar-targeted therapy in nmcrpc
-
6:32
what is the preferred molecular testing method to detect ret in nsclc?
-
5:33
an mpn expert defines clinical trial types